About Marc Lippman
Form D filings for Revere Pharmaceuticals from 2021 to 2023 list Marc Lippman as director.
Marc Lippman first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Marc Lippman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Marc Lippman works with at each company, as listed on that company's latest Form D.
Revere Pharmaceuticals Inc. · Form D, Jun 12, 2023
KP
Kollol Pal
Director
IS
Ian Silverman
President and Chief Executive Officer, director
JL
Jedd Levine
Executive officer and director